Colchicine in Acute Myocardial Infarction | NEJM
Inflammation is associated with adverse cardiovascular events. Data from recent trials suggest that colchicine reduces the risk of cardiovascular events. In this multicenter trial with a 2-by-2 fac…
Related Articles
Transcatheter Valve Repair for Mitral Regurgitation | NEJM
Quick Take Video Summary from The New England Journal of Medicine — Transcatheter Valve Repair for Mitral Regurgitation
CRISPR-Cas9 Gene Editing with Nexiguran Ziclumeran for ATTR Cardiomyopathy | NEJM
Transthyretin amyloidosis with cardiomyopathy (ATTR-CM) is a progressive, often fatal disease. Nexiguran ziclumeran (nex-z) is an investigational therapy based on CRISPR-Cas9 (clustered regularly i…
Left Atrial Appendage Closure after Ablation for Atrial Fibrillation | NEJM
Oral anticoagulation is recommended after ablation for atrial fibrillation among patients at high risk for stroke. Left atrial appendage closure is a mechanical alternative to…
Routine Spironolactone in Acute Myocardial Infarction | NEJM
Mineralocorticoid receptor antagonists have been shown to reduce mortality in patients after myocardial infarction with congestive heart failure. Whether routine use of spironolactone is beneficial…
Prevalence, Penetrance, and Phenotypic Manifestation of Cardiomyopathy-Associated Genetic Variants in the General Population: Insights from a Mayo Clinic Biobank Study
To determine the prevalence, penetrance, and disease expression of cardiomyopathy-related genetic variants in an unselected, richly phenotyped Mayo Clinic population in the setting of preemptive…
Catheter Ablation or Antiarrhythmic Drugs for Ventricular Tachycardia | NEJM
Patients with ventricular tachycardia and ischemic cardiomyopathy are at high risk for adverse outcomes. Catheter ablation is commonly used when antiarrhythmic drugs do not suppress…
Graves’ disease: are we just delaying the inevitable?
Paediatric Graves’ disease (GD) is caused by thyroid-stimulating hormone receptor antibody stimulation of the thyroid. The European Thyroid Association recently produced GD guidelines.1 Anti-thyroid drugs…
Intensive Blood-Pressure Control in Patients with Type 2 Diabetes | NEJM
Effective targets for systolic blood-pressure control in patients with type 2 diabetes are unclear. We enrolled patients 50 years of age or older with type…
Routine Spironolactone in Acute Myocardial Infarction | NEJM
Mineralocorticoid receptor antagonists have been shown to reduce mortality in patients after myocardial infarction with congestive heart failure. Whether routine use of spironolactone is beneficial…
November 14, 2024 | NEJM
Image Challenge from the New England Journal of Medicine — November 14, 2024